ATE403153T1 - Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403153T1
ATE403153T1 AT01978211T AT01978211T ATE403153T1 AT E403153 T1 ATE403153 T1 AT E403153T1 AT 01978211 T AT01978211 T AT 01978211T AT 01978211 T AT01978211 T AT 01978211T AT E403153 T1 ATE403153 T1 AT E403153T1
Authority
AT
Austria
Prior art keywords
biological cell
test
related biological
body fluid
fluid sample
Prior art date
Application number
AT01978211T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403153T1 publication Critical patent/ATE403153T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
    • G01N2333/135—Respiratory syncytial virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01978211T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe ATE403153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001549 2000-10-17
US24213200P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403153T1 true ATE403153T1 (de) 2008-08-15

Family

ID=26068896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978211T ATE403153T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Country Status (9)

Country Link
US (1) US6790611B2 (de)
EP (1) EP1340086B1 (de)
JP (1) JP2004511807A (de)
AT (1) ATE403153T1 (de)
AU (2) AU2002210384B2 (de)
CA (1) CA2463678A1 (de)
DE (1) DE60135147D1 (de)
DK (1) DK1340086T3 (de)
WO (1) WO2002033417A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001295442A1 (en) * 2000-10-17 2002-04-29 Besst-Test Aps Assay for directly detecting an inflammatory indicator in a body fluid sample
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
US20090314946A1 (en) * 2002-08-27 2009-12-24 Kimberly-Clark Worldwide, Inc. Membrane-Based Assay Devices that Utilize Time-Resolved Fluorescence
US20040219690A1 (en) * 2003-05-02 2004-11-04 Choi Young Ho Chromatographic assay system
WO2005031355A1 (en) * 2003-09-22 2005-04-07 Quidel Corporation Devices for the detection of multiple analytes in a sample
US20060046310A1 (en) * 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
DK2645106T4 (da) 2005-04-04 2024-12-02 Biogen Ma Inc Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
US20070207141A1 (en) 2006-02-28 2007-09-06 Ivan Lieberburg Methods of treating inflammatory and autoimmune diseases with natalizumab
MX2008011176A (es) 2006-03-03 2008-09-10 Elan Pharm Inc Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab.
GB0612825D0 (en) * 2006-06-28 2006-08-09 Iti Scotland Ltd Analyte detection
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
US20100178652A1 (en) * 2007-01-05 2010-07-15 Litherland Sally A Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
US9086408B2 (en) 2007-04-30 2015-07-21 Nexus Dx, Inc. Multianalyte assay
EP2140265B1 (de) * 2007-03-22 2012-10-31 Scandinavian Micro Biodevices A/S Durchflusssystem, durchflussvorrichtung und verfahren zur durchführung eines tests
WO2008154813A1 (fr) 2007-06-15 2008-12-24 Xiamen University Anticorps monoclonaux se liant à l'hémagglutinine du virus de la grippe aviaire du sous type h5 et ses utilisations
US20090208975A1 (en) * 2007-12-13 2009-08-20 Beckman Coulter, Inc. Device and methods for detecting a target cell
US9285361B2 (en) * 2008-07-03 2016-03-15 Johnson & Johnson Ab Method for the analysis of circulating antibodies
JP5575377B2 (ja) * 2008-07-18 2014-08-20 シスメックス株式会社 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
ES2666372T3 (es) 2009-10-11 2018-05-04 Biogen Ma Inc. Ensayos relacionados con anti-VLA-4
CN102906278A (zh) 2010-01-11 2013-01-30 比奥根艾迪克Ma公司 用于jc病毒抗体的测定
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
DK2715352T3 (da) 2011-05-31 2019-05-20 Biogen Ma Inc Fremgangsmåde til vurdering af risiko for pml
CL2011003002A1 (es) 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
WO2014051141A1 (ja) * 2012-09-28 2014-04-03 積水メディカル株式会社 無希釈系イムノクロマトグラフ法試薬において希釈試料を測定するための添加物
MX2015008108A (es) * 2012-12-20 2015-11-06 Novartis Ag Lesion renal aguda.
WO2014193804A1 (en) 2013-05-28 2014-12-04 Biogen Idec Ma Inc. Method of assessing risk of pml
JP6454274B2 (ja) * 2013-06-21 2019-01-16 アルフレッサファーマ株式会社 Ｒｓｖを検出するためのイムノクロマトグラフィー装置
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
SG11201608278WA (en) 2014-04-02 2016-10-28 Chembio Diagnostic Systems Inc Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
JP2016164553A (ja) * 2015-02-27 2016-09-08 株式会社リコー 標的検査装置、標的検査キット、標的検査方法、転写媒体、及び標的検査装置の製造方法
US9867250B1 (en) 2015-04-20 2018-01-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona System having a configurable pico-second pulsed LED driver circuit and photomultiplier tube biasing and gating circuits for real-time, time-resolved transient recording of fluorescence
KR102567398B1 (ko) 2015-08-06 2023-08-17 리아 다이아그노스틱스, 인크. 물 분산성 분석
US12421626B2 (en) 2018-06-29 2025-09-23 Fred Hutchinson Cancer Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
EP3848389A4 (de) 2018-09-03 2022-04-13 Pontificia Universidad Católica De Chile Spezifischer monoklonaler antikörper gegen das n-antigen des humanen respiratorischen synzytialvirus (hrsv) zur behandlung von infektionen, deren nachweis und diagnose
JP7808851B2 (ja) * 2020-02-25 2026-01-30 ヘリックスバインド・インコーポレイテッド 流体システムのための試薬キャリア
EP4127713A1 (de) * 2020-03-26 2023-02-08 Security Matters Ltd. Vorrichtung und verfahren zum nachweis von viren durch xrf
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
ATE161963T1 (de) 1989-06-06 1998-01-15 Ampcor Inc Reagenziensatz für immunoassay
CA2023850A1 (en) * 1989-09-28 1991-03-29 Randal A. Hoke Stabilizing reagent for membrane immunoassay
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
DK130991D0 (da) * 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
CA2113823A1 (en) * 1991-07-19 1993-02-04 Cytimmune Sciences, Inc. Method and kit for measuring endogenous cytokines
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
DE69332643T2 (de) * 1992-09-16 2003-11-27 The Scripps Research Institute, La Jolla Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus
EP0777685B1 (de) * 1994-08-25 1999-04-14 Stichting Instituut voor Dierhouderij en Diergezondheid Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv-infektionen
US6083708A (en) * 1995-08-11 2000-07-04 Dade Behring Inc. Polypeptide: dendrimer complexes
AU7081796A (en) * 1995-10-03 1997-04-28 Universite De Montreal Diagnostic kit for bovine syncytial respiratory virus
JP3601972B2 (ja) * 1998-05-14 2004-12-15 松下電器産業株式会社 色素標識タンパク質複合体およびその製造方法
WO1998038513A1 (en) * 1997-02-26 1998-09-03 Khaw Ban An Signal enhancement of bispecific antibody-polymer probe for immunoassay use
ES2286852T3 (es) * 1997-08-04 2007-12-01 Advanced Life Science Institute, Inc. Metodos para detectar o analizar virus.

Also Published As

Publication number Publication date
EP1340086A1 (de) 2003-09-03
CA2463678A1 (en) 2002-04-25
JP2004511807A (ja) 2004-04-15
WO2002033417A1 (en) 2002-04-25
DE60135147D1 (de) 2008-09-11
US6790611B2 (en) 2004-09-14
AU1038402A (en) 2002-04-29
DK1340086T3 (da) 2008-12-01
US20020081573A1 (en) 2002-06-27
AU2002210384B2 (en) 2006-10-19
EP1340086B1 (de) 2008-07-30

Similar Documents

Publication Publication Date Title
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
EP1532267A4 (de) Teststreifen zum analytnachweis und verwendungsverfahren
EP0805215A3 (de) Diagnostische Methoden und Proben
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
WO2001038873A3 (en) Devices and methods for detecting analytes using electrosensor having capture reagent
WO2002033410A3 (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
WO2004055205A3 (en) Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
AU6775201A (en) Improved capture and detection of target nucleic acid in dipstick assays
DE69737628D1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
DE60225802D1 (de) Verfahren und gerät zum nachweis des gesamten proteingehaltes bei niedrigen ph-werten
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
ATE478337T1 (de) Methoden zum nachweis analyten in proben
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
DE60038557D1 (en) Assay
WO2002004122A3 (en) Improved stability of hybridisation interactions in dipstick assays
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen
GB0304832D0 (en) Assay method
CA2671474A1 (en) A method for detecting human parvovirus antigen
ATE278965T1 (de) Knorpelresorptionsassays

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties